system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: UNLABELLED. Meshes: Analgesics, Non-Narcotic, Diagnostic Imaging, Humans, Magnetic Resonance Imaging, Molecular Targeted Therapy, Nerve Growth Factor, Osteoarthritis, Pain, Risk Factors.
user
Is 7th International Workshop on Osteoarthritis Imaging report : `` imaging in OA -- now the time to move ahead ''? Context: The 7th Osteoarthritis Research Society International (OARSI) International Workshop on Osteoarthritis Imaging was held in Reykjavik, Iceland, from July 9-12, 2014; attracting attendees from academia, pharmaceutical and Magnetic resonance imaging (MRI) industries, as well as a large number of young investigators. The Workshop program consisted of six modules, including imaging in osteoarthritis (OA), imaging and pain in OA, new techniques in imaging, risk factors and structural outcomes, anti-nerve growth factor (a-NGF) therapy, and joint replacement. A wealth of data was presented from OA researchers from all over the world and participants gained insightful knowledge on up-to-date research work focusing on imaging of OA. This paper presents a summary of the salient points from the workshop.
assistant
Identifying the appropriate imaging modality and parameters will be critical for ensuring responsive, reproducible and reliable outcomes for clinical trials. Continued efforts from the OA research community are needed to establish the most effective use of imaging in OA clinical trials, including anti-NGF therapy and joint replacement trials, and to validate newer imaging techniques such as compositional MRI for use in the future clinical trials. Final Decision: yes